Lasibrace Injection 4ml

About

Lasibrace Injection 4ml, likely containing a potent diuretic such as furosemide, is administered parenterally to achieve rapid and effective reduction of fluid overload. This medication is crucial in acute clinical settings where immediate diuresis is required, such as in cases of severe congestive heart failure, acute pulmonary edema, or certain forms of renal failure with oliguria. Its mechanism of action involves inhibiting the reabsorption of sodium and chloride in the renal tubules, particularly the loop of Henle, leading to a significant increase in the excretion of water and electrolytes.

The injectable formulation ensures a quick onset of action, providing prompt relief from symptoms like dyspnea and peripheral edema. Healthcare professionals carefully monitor fluid and electrolyte balance during its use to prevent complications, ensuring patient safety and optimal therapeutic outcomes in critical situations requiring rapid fluid removal.

Uses

• Acute pulmonary edema
• Severe congestive heart failure
• Acute renal failure with oliguria
• Hypertensive crisis (adjunctive therapy)

Directions For Use

Administered intravenously or intramuscularly by a qualified healthcare professional.

Benefits

• Rapid onset of action
• Highly effective in severe fluid overload
• Reduces blood pressure quickly
• Improves respiratory function in emergencies
• Helps manage acute heart failure exacerbations
• Suitable for critical care settings

Side Effects

• Dehydration
• Electrolyte imbalance (e.g., hypokalemia, hyponatremia)
• Hypotension (low blood pressure)
• Dizziness
• Ototoxicity (hearing loss, tinnitus)
• Muscle cramps
• Nausea
• Vomiting
• Blurred vision
• Skin rash
• Hyperglycemia
• Gout exacerbation

Safety Measures

• Alcohol - Avoid or limit alcohol consumption as it can exacerbate dizziness and hypotension, increasing the risk of falls.
• Pregnancy - Use only if clearly needed; potential risks to the fetus, especially electrolyte imbalance, should be considered.
• Breastfeeding - Not recommended; the active ingredient can suppress lactation and pass into breast milk, potentially affecting the infant.
• Liver - Use with caution in patients with severe liver disease; risk of hepatic encephalopathy may be increased.
• Kidney - Use with caution in severe renal impairment; monitor fluid and electrolytes closely to prevent complications.
• Lung - No specific contraindications, but monitor for electrolyte imbalances that could indirectly affect respiratory muscle function.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.